Accutane Class Action

Accutane Class Action Kim Spencer McPhee is working with a consortium of firms across Canada on a claim Claim alleges tha Hoffmann-La Roche, Ltd. McPhee at [email protected].

Kim Spencer McPhee is working with a consortium of firms across Canada to consolidate class actions started in various provinces against Hoffmann-La Roche Ltd Hoffmann-La Roche Limitee, F. AG, Roche Holding Ltd., and Hoffmann-La Roche Inc. (collectively, "Hoffmann-La Roche") seeking damages as a result of Hoffmann-La Roche's development, manufacture and sale of Accutane. Accutane was recommended a

nd prescribed for the treatment of severe acne. The Statement of Claim will be amended and Kim Spencer McPhee will bring a motion for the certification of this action as a class proceeding. The Claim alleges that Accutane causes significant risks, including Inflammatory Bowel Disease. The Claim alleges that Hoffmann La-Roche knew of the health risks associated with consuming Accutane, but failed to warn doctors, patients, and regulators, including Health Canada and the FDA, of those risks. The Claim seeks damages on behalf of all persons in Canada who were prescribed and who took Accutane, and their family members. For more information about this class action, please contact Megan B.

05/20/2021

Update: On February 9, 2021, the Ontario Superior Court of Justice dismissed the action on consent of the parties. The dismissal followed an evolution in the science since the action commenced that gave rise to considerable uncertainty regarding a causal link between Accutane use and IBD. This in turn also led to the dismissal of Accutane-related litigation in the United States. To read the Court’s decision, please click file:///C:/Users/dbj/Downloads/Patkus-v-Hoffman-discontinuance-Reasons-for-Decision%20(1).pdf. To see the order, please click fil:///C:/Users/dbj/Downloads/Patkus-v-Hoffman-discontinuance-order.pdf .

**Please note that dismissal of this proposed class proceeding may impact the limitation period applicable to any potential claims related to Accutane. Please seek legal advice immediately if you are thinking of starting an action.**

Address

79 Wellington Street West, Suite 2100, PO Box 139
Toronto, ON
M5K1H1

Telephone

+14165961414

Website

Alerts

Be the first to know and let us send you an email when Accutane Class Action posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Accutane Class Action:

Shortcuts

Featured

Share

Category